Form 4: Danimer Scientific Director Acquires Shares Through Restricted Stock Unit Vesting

Sentiment:

SEC Form 4 Filing


Director Stuart W. Pratt acquired 16,611 shares of Danimer Scientific Class A Common Stock on June 1, 2024, through the vesting of restricted stock units.

Summary

  • On June 1, 2024, Stuart W. Pratt, a director of Danimer Scientific, Inc., acquired 16,611 shares of Class A Common Stock.
  • This acquisition resulted from the vesting of restricted stock units (RSUs) granted as director compensation under the company's 2020 Long-Term Incentive Plan.
  • Each RSU represents the right to receive one share of Danimer Scientific Class A Common Stock.
  • Following the transaction, Pratt directly owns 1,450,717 shares of Class A Common Stock.
  • The vesting of these RSUs was contingent upon Pratt's continued service as a director of the company.
  • A Limited Power of Attorney was executed on June 4, 2023, authorizing Stephen A. Martin, Spencer E. Walker, Michael S. Nancarrow, and Blake R. Chamblee to act on Pratt's behalf for Section 16 reporting and Form 144 obligations.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (vesting of RSUs) and doesn't contain overtly positive or negative information. It's a neutral event in terms of sentiment.

Positives

  • The vesting of RSUs indicates continued director engagement and alignment with the company's long-term performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Director compensation packages often include restricted stock units (RSUs) that vest over time, aligning director interests with shareholder value.
  • The vesting schedule of RSUs is a common practice among publicly traded companies to incentivize long-term commitment from directors.

Stakeholder Impact

  • The transaction increases the director's stake in the company, potentially aligning their interests more closely with those of shareholders.

Key Dates

DateDescription
06/04/2023Date of execution of the Limited Power of Attorney.
06/01/2024Date of transaction: vesting of restricted stock units and acquisition of shares.
06/04/2024Date of signature of the Form 4 filing.

Keywords

Danimer Scientific, Director, Stuart W. Pratt, Restricted Stock Units, RSU, Class A Common Stock, Beneficial Ownership, Form 4, SEC, Section 16, Power of Attorney

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.